International Exchange| SCIMEA accompanied the Consul-General of Japan in Chongqing to visit the Sincerity and Compassion Health Management Center

2020-10-26

Open the phone and scan

China and Japan are facing commo n health challenges, and two countries should join hands, combine each other's strengths and focus on developing general health industry for the benefit of the people of the two countries.


On July 1, Mr. Shinyuki Watanabe, Consulate-General of Japan in Chongqing, accompanied by the Sichuan International Medical Exchange & Promotion Association (SCIMEA), visited Japan's high-end medical project introduced by Leading Group -- Sincerity and Compassion Health Management Center. Mr. Watanabe was impressed by the combination of high-quality resources from China and Japan, and he acknowledged the rapid development of all-Japanese health management services introduced by Sincerity and Compassion Health Management Center in China.


Ms. Mengfan Zhang, along with Secretary-General of SCIMEA, Ms. Xiawei Wei, Member of biological immunotherapy professional committee of SCIMEA, Ms. Miaomiao Liu, China representative of Kobe Translational Research Center for Medical Innovation (TRI) and Ms. Lai Tian, Director of International Communication Department of SCIMEA, accompanied with Mr. Shinyuki Watanabe for the visit at Sincerity and Compassion Health Management Center in Chengdu. Mr. Jiang Zhu, Group director and President of Sincerity and Compassion Health Management Center and other senior leaders, accompanied the visit and discussion.

 

 

Japan is a country with a well-developed general health industry, and it is at the forefront of the world in terms of health care, health checkups and health management. With the increasing demand for universal health care, the traditional and single medical treatment model has been transformed into disease prevention, health care and health promotion.

During the meeting, Mr. Jiang Zhu, President of Sincerity and Compassion Health Management Center, said that China and Japan are neighbors separated by a strip of water. The two countries have similar cultures and a long history of contacts. Moreover, the two countries share the same direction of development of the general health industry, which is to make the people stay healthy and long-lived. On the purpose of benefiting the health of the people, Sincerity and Compassion Health Management Center will consider the actual conditions of the country and spare no effort to develop the essence of Japanese health management and promote the culture of all-Japanese health management to a new level in China.



Sincerity and Compassion Health Management Center


China and Japan began to maintain good cooperation at the "2019 China-Japan Advanced Medicine and New Drug R&D and Achievement Transformation Conference". Mr. Nobuyuki Watanabe, Consul General of the Japanese Consulate in Chongqing, attended the conference as a guest. At the meeting, Mr. Nobuyuki Watanabe said that there is great potential for cooperation between China and Japan in the research and development of new drugs. Japan has the highest-end technology and achievements comparable to those in Europe and America in the field of medical research and development. Meanwhile, China's Chinese medicine as a special and unique medical system has thousands of years of experience, and many traditional Chinese medicine prescriptions accumulated in many years of practice, "I learned that China is actively engaged in the development of pharmaceuticals. Moreover, in recent years, China has developed very fast in the fields of big data and AI. So, I believe this will also facilitate professional communication between the two countries in the field of medicine.”


The visit of Mr. Shinyuki Watanabe to Japan's high-end medical project introduced by Leading Group is the full play of the SCIMEA's advantages of international exchanges. Through intercommunication, integration of resources from all sides, open channels for overseas medical centers and assist experts to visit China for exchange, to help the development of Sino-Japanese medical exchanges and strengthen the exchange and cooperation between China and Japan. SCIMEA plays an increasingly important role in international cooperation, scientific research promotion and achievement transformation.  Sichuan International Medical Exchange & Promotion Association (SCIMEA) will continue to exert its advantages in resource integration, project transformation and industrial upgrading in the promotion of international medical exchange. And make full use of the combined strengths of China and Japan, release the vitality and potential of the health industry at multiple levels and in various dimensions, and promote the rapid development of medical industry in both countries.